Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell function
Fabio HB da Costa, Mutsuki Kawabe, Tsung-You Tsai, Kento Okamoto, Mason D. Bartels, Sofia Cortes, Ratna Veeramachaneni, Roberto Rangel, Mitchell J. Frederick, Vlad C. Sandulache, Andrew G. Sikora, Jeffrey N. Myers, Abdullah A. Osman · 2026
Read Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell function by Fabio HB da Costa, Mutsuki Kawabe, Tsung-You Tsai, Kento Okamoto, Mason D. Bartels, Sofia Cortes, Ratna Veeramachaneni, Roberto Rangel, Mitchell J. Frederick, Vlad C. Sandulache, Andrew G. Sikora, Jeffrey N. Myers, Abdullah A. Osman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13315458.txt.
Description
Fabio HB da Costa and co-authors tested in 2026 whether blocking the ATR kinase can help immune therapy work better in head and neck cancer. The drug AZD6738 was studied in squamous cell cancer of the head and neck, a common cancer where over half of patients still die of the disease.
Adding ATR blockade strengthened anti-PD-1 treatment by reshaping the tumor immune setting. Killer T cells rose, while regulatory T cells and suppressive myeloid cells fell. The treatment also pushed macrophages toward an attacking state through the cGAS and STING pathway, cut STAT3 activity, raised interferon signals, and lowered a cell-change program tied to spread.
Catalog record
| CREATOR | Fabio HB da Costa, Mutsuki Kawabe, Tsung-You Tsai, Kento Okamoto, Mason D. Bartels, Sofia Cortes, Ratna Veeramachaneni, Roberto Rangel, Mitchell J. Frederick, Vlad C. Sandulache, Andrew G. Sikora, Jeffrey N. Myers, Abdullah A. Osman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76677 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |